264 related articles for article (PubMed ID: 9150356)
21. Dpc4 transcriptional activation and dysfunction in cancer cells.
Dai JL; Turnacioglu KK; Schutte M; Sugar AY; Kern SE
Cancer Res; 1998 Oct; 58(20):4592-7. PubMed ID: 9788608
[TBL] [Abstract][Full Text] [Related]
22. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
Iglesias M; Frontelo P; Gamallo C; Quintanilla M
Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
[TBL] [Abstract][Full Text] [Related]
23. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
24. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
25. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.
Duda DG; Sunamura M; Lefter LP; Furukawa T; Yokoyama T; Yatsuoka T; Abe T; Inoue H; Motoi F; Egawa S; Matsuno S; Horii A
Oncogene; 2003 Oct; 22(44):6857-64. PubMed ID: 14534532
[TBL] [Abstract][Full Text] [Related]
26. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
Lagna G; Hata A; Hemmati-Brivanlou A; Massagué J
Nature; 1996 Oct; 383(6603):832-6. PubMed ID: 8893010
[TBL] [Abstract][Full Text] [Related]
27. Effect of transforming growth factor-beta1 on the cell growth and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines.
Fukuda M; Ikuta K; Yanagihara K; Tajima M; Kuratsune H; Kurata T; Sairenji T
Virology; 2001 Sep; 288(1):109-18. PubMed ID: 11543663
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of mouse mast cell protease-6 gene by transforming growth factor-beta and activin in mast cell progenitors.
Funaba M; Ikeda T; Murakami M; Ogawa K; Abe M
Cell Signal; 2005 Jan; 17(1):121-8. PubMed ID: 15451032
[TBL] [Abstract][Full Text] [Related]
29. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
30. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
Hummer BT; Bartlett C; Henry E; Weissman BE
J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
[TBL] [Abstract][Full Text] [Related]
31. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
32. Regulation of transforming growth factor beta- and activin-induced transcription by mammalian Mad proteins.
Chen Y; Lebrun JJ; Vale W
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12992-7. PubMed ID: 8917532
[TBL] [Abstract][Full Text] [Related]
33. A transcriptional partner for MAD proteins in TGF-beta signalling.
Chen X; Rubock MJ; Whitman M
Nature; 1996 Oct; 383(6602):691-6. PubMed ID: 8878477
[TBL] [Abstract][Full Text] [Related]
34. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
35. Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.
Zhou S; Buckhaults P; Zawel L; Bunz F; Riggins G; Dai JL; Kern SE; Kinzler KW; Vogelstein B
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2412-6. PubMed ID: 9482899
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
[TBL] [Abstract][Full Text] [Related]
37. Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.
Ji H; Stout LE; Zhang Q; Zhang R; Leung HT; Leung BS
J Cell Biochem; 1994 Mar; 54(3):332-42. PubMed ID: 8200913
[TBL] [Abstract][Full Text] [Related]
38. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
39. DPC4 gene in various tumor types.
Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE
Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691
[TBL] [Abstract][Full Text] [Related]
40. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
